Paper #1139

Título:

Hybrid risk adjustment for pharmaceutical benefits

Autores:

Manuel García-Goñi, Pere Ibern y José María Inoriza

Fecha:

Enero 2009

Resumen:

This paper analyses the application of hybrid risk adjustment versus either prospective or concurrent risk adjustment formulae in the context of funding pharmaceutical benefits for the population of an integrated healthcare delivery organization in Catalonia during years 2002 and 2003. We apply a mixed formula and find that a hybrid risk adjustment model increases incentives for efficiency in the provision of low risk individuals at health organizations not only as a whole but also at each internal department compared to only prospective models by reducing within-group variation of drug expenditures.

Palabras clave:

Drug expenditure, hybrid risk-adjustment, morbidity, clinical risk groups

Códigos JEL:

I18

Área de investigación:

Economía Laboral, Pública, de Desarrollo y de la Salud

Número serie CRES:

63

Descargar el paper en formato PDF